MLAB
Mesa Laboratories Inc /Co/
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Company with tickers: MLAB
CIK
724004
CUSIP
59064R109
Shares Outstanding
5,524,931
Website
https://www.mesalabs.com
Investor Relations
https://investors.mesalabs.com/home/default.aspx
13F Activity (30d)
12 filings
9 filers
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
55/100
Short interest 5.1% of shares — P73
Days to cover 1.3 — P33
Short-volume trend +1.8% — P59
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-05-29). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-03-31 | 220,739 | 224,457 | -3,718 | 2.03 |
| 2026-04-15 | 198,395 | 220,739 | -22,344 | 1.89 |
| 2026-04-30 | 198,615 | 198,395 | +220 | 1.84 |
| 2026-05-15 | 232,139 | 198,615 | +33,524 | 1.68 |
| 2026-05-29 | 279,822 | 232,139 | +47,683 | 1.33 |
Showing 1–5 of 5 settlements